Skip to main content
Premium Trial:

Request an Annual Quote

Courtagen Inks Distribution Deals for Israel, Thailand

NEW YORK (GenomeWeb) – Courtagen Life Sciences today announced distribution agreements for its genetic tests in Israel and Thailand. 

The deals are with Pronto Diagnostics, headquartered in Tel Aviv, Israel and Medica Labs, based in Bangkok, Thailand. Financial and other terms of the agreements were not disclosed. 

Courtagen's tests use next-generation sequencing for the discovery of the genetic underpinnings of diseases including epilepsy, mitochondrial disorders, developmental delay, and lysosomal storage disorders to help guide treatment. 

"Pronto offers genetic testing services to all of the Israeli healthcare providers and this new addition aligns with the company’s strategy of presenting the local market with the world's leading tests in specific clinical fields," Pronto President Nir Navot said in a statement.